![]() |
|
|
Vol. 20, Issue 20, 4313-4323, October 15, 2009
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||

*Department of Anatomy and Cell Biology, University of Western Ontario, London, Ontario N6A 5C1, Canada; and
Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario L8N3Z5, Canada
Submitted January 22, 2009;
Revised July 17, 2009;
Accepted August 10, 2009
Monitoring Editor: Reid Gilmore
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
Panx1 and Panx3 have been reported to be glycoproteins, capable of assembling into functional single-membrane channels at the plasma membrane (Boassa et al., 2007
; Penuela et al., 2007
). In vivo, Panx1 and Panx3 have been reported to be coexpressed in mouse skin, osteoblasts, and specialized cartilage (Baranova et al., 2004
; Penuela et al., 2007
). Panx1 and Panx2, in contrast, have been found in retina, lens, cochlea, cerebellum, and brain (Bruzzone and Dermietzel, 2006
; Ray et al., 2006
; Dvoriantchikova et al., 2006a
,b
; Tang et al., 2008
). Very little is known about the posttranslational modifications or functional properties of Panx2. Even though two or more Pannexin (Panx) family members are coexpressed within many cell types, it is not known whether they intermix or whether intermixing would regulate channel function. Previous evidence that such intermixing might exist for any combination of Panxs was deduced from Xenopus oocyte studies where coexpression of Panx2 attenuated Panx1 channels (Bruzzone et al., 2003
, 2005
).
Connexins, in contrast, the vertebrate family of gap junction proteins, have been extensively reported to form mixed channels of co-oligomerized connexins (Harris, 2007
). The connexin family of gap junction proteins has 20 members in rodent genomes and based on their sequence homologies have been divided into several subgroups (Willecke et al., 2002
). Connexins of the same subgroup often have the capacity to hetero-oligomerize and form mixed channels that confer unique properties to the channels that select for transjunctional permeable molecules (Koval, 2006
; Harris, 2007
). However, although connexins provide proof-of-principle that family members can intermix, these frequently phosphorylated molecules (Solan and Lampe, 2005
) are quite distinct from the pannexin family of glycoproteins. Thus, in the present study, we further assessed the glycosylation and functional status of all mouse pannexin family members and examined how glycosylation regulates the channel function of pannexins and their ability to cointeract.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Peptide sequences from each of the main domains of the pannexin proteins were tested for potential antigenicity and used to generate site-directed rabbit polyclonal antibodies by Genemed Synthesis (San Antonio, TX). Specific peptides (Table 1) were synthesized, tagged with keyhole limpet hemocyanin through an extra C-terminal cysteine, and injected into rabbits for generation of antisera. Immunoblotting and immunofluorescent analysis were used to test preimmune sera and antisera before the selection of the antibodies that would be affinity purified against the corresponding peptides by Genemed Synthesis (Table 1). Selected antibodies were denoted by their corresponding domain (EL1, first extracellular loop; EL2, second extracellular loop; IL, intracellular loop; CT, carboxy terminus) and the first amino acid in the peptide sequence used to generate the antibody. All of the affinity-purified antibodies were used in immunoblotting and immunofluorescent assays for characterizing the pannexins. For most studies, the Panx1 CT-395 and Panx3 CT-379 antibodies (reported previously by Penuela et al., 2007
) were used. For Panx2 immunolabeling, the CT-494 sera was used, whereas the rabbit anti-mouse Panx2 antibody from Invitrogen (Burlington, ON, Canada) was used for all Panx2 immunoblots shown. Thus, to simplify the description of these antibodies in the text and figures, they are referred to as anti-Panx1, Panx2, and Panx3 antibodies.
|
Cell Lines and Culture Conditions
Media and reagents were obtained from Invitrogen, Sigma-Aldrich (St. Louis, MO), and BD Biosciences (Mississauga, ON, Canada). Normal rat kidney (NRK), mouse osteoblastic cells (MC3T3-E1), and human embryonic kidney cells (293T) were obtained from American Type Culture Collection (Manassas, VA). Cells were grown in high-glucose DMEM, or
-minimum essential medium (MEM) for MC3T3-E1, supplemented with 10% fetal bovine serum, 100 U/ml penicillin, 100 µg/ml streptomycin, and 2 mM L-glutamine.
Transient Expression
For transient transfections, mammalian cells grown to 50–75% confluence in 35- or 100-mm (for biotinylation and coimmunoprecipitation [co-IP]) culture dishes were transfected in Opti-MEM I media with Lipofectamine2000 (Invitrogen) and 1 or 5 µg of plasmid DNA, respectively, for 4 h at 37°C as described previously (Penuela et al., 2007
). For coexpression assays, equal amounts of each construct were transfected at a 1:1 ratio. After 48 h, transfections were evaluated by immunofluorescence.
Immunocytochemistry
Coverslips with cultured cells were immunolabeled as described previously for Panx1 CT-395 and Panx3 CT-379 (Penuela et al., 2007
), by using a final concentration of 2 µg/ml for each affinity-purified antibody. Preimmune sera and antisera for the new anti-pannexin antibodies were tested at 1:500 dilutions, and the affinity-purified antibodies were used at 2 µg/ml. Peptide preadsorption assays were performed for all antibodies at 20:1 M excess of the peptide with respect to the antibody, as described previously (Penuela et al., 2007
). Because all antibodies were generated in rabbits, for double labeling of Panx1 with Panx2 or Panx3, we generated a Panx1 CT-395 antibody directly labeled with Fluor 488, by using the DyLight 488-microscale antibody labeling kit (Pierce Chemical, Rockford, IL) according to manufacturer's instruction. This fluorochrome-labeled antibody was used for direct labeling of Panx1 after immunolabeling of coexpressed pannexins in cultured cells. The labeled antibody was used at 2 µg/ml and incubated for 1 h at room temperature, followed by washes with phosphate-buffered saline (PBS) and distilled deionized water, before mounting. Analysis was performed on an LSM 510 inverted confocal microscope (Carl Zeiss, Thornwood, NY) by using a 63x oil immersion objective.
Western Blotting and Deglycosylation Assays
Cell lysates from control 293T cells or 293T cells expressing pannexins were collected from cultures by using a Triton-based extraction buffer as described previously (Penuela et al., 2007
). N-Glycosidase F assays were performed according to the manufacturer's instructions (Roche Applied Science, Laval, QC, Canada). Using 35 µg of total protein with or without 10 U of the glycosidase and incubated for either 60 or 15 min at 37°C (the different incubation times allow for the estimation of the number of glycan chains bound to the glycoprotein) (Tarentino and Plummer, 1987
). Endoglycosidase H (EndoH) digestion of 35 µg of total protein per sample was done at 37°C for 1 h, by using 5000 U of the enzyme, in parallel with control samples that did not contain EndoH. Digestion with EndoH was used to detect the presence of high-mannose modification, whereas more complex forms of glycosylation are known to be resistant to digestion. Protein samples were separated on an 8% SDS-polyacrylamide gel electrophoresis gel (PAGE) and transferred to nitrocellulose membranes. Membranes were processed for immunoblotting as described previously (Penuela et al., 2007
) by using the selected antibodies for Panx1, Panx2 (Zymed Laboratories, South San Francisco, CA/Invitrogen), and Panx3, as well as for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as a loading control. All protein standards are depicted in kilodaltons.
Cell Surface Biotinylation Assays
293T cells expressing Panx1 and/or Panx2, Panx3, or the N-glycosylation–deficient mutants of Panx1 and Panx3 described by Penuela et al. (2007)
were subjected to cell surface biotinylation 48 h after transfection. All reagents and cultures were kept on ice during the biotinylation assay. In brief, cultures were washed three times with ice-cold PBS. Control plates were incubated in PBS, whereas test plates were incubated with the same solution containing EZ-link NHS-LC-biotin or EZ-link Sulfo NHS-LC biotin (1 mg/ml; Pierce Chemical) for 20 min at 4°C. Cultures were washed once with PBS containing 100 mM glycine and then incubated in glycine buffer for 15 min at 4°C to quench the biotin. Cells were then lysed with SDS lysis buffer (1% Triton X-100 and 0.1% SDS in PBS). Lysates were rocked at 4°C for 1 h, and supernatants were subjected to bicinchoninic acid test (Pierce Chemical) for quantification. Equal amounts of protein lysate (750–1000 µg) from control and biotin samples were incubated overnight with 50 µl of NeutrAvidin-agarose beads (Pierce Chemical). Beads were washed three times with IP lysis buffer (150 mM NaCl, 10 mM Tris-HCl, pH 7.4, 1 mM EDTA, 0.5% NP-40, and 1% Triton X-100) containing 1 mM NaF and 1 mM Na3VO4, and once with PBS, and then dried by aspiration. The beads were resuspended in 2x Laemmli buffer (under reducing conditions), boiled for 5 min, resolved by SDS-PAGE, and transferred to nitrocellulose membranes to be probed with the corresponding anti-Panx1, -Panx2, or -Panx3 antibodies. In parallel, an aliquot of 20 µg of total protein lysate was subject to immunoblot analysis. GAPDH (an intracellular protein) was used as a control to detect any unexpected biotin internalization. Quantification of biotinylated proteins in immunoblots of Panx2-expressing cell lysates or Panx1- and Panx2-coexpressing cells was processed using the Odyssey infrared-imaging system (LI-COR, Lincoln, NE). Densitometry readings of three independent experiments were analyzed using a Student's t test (p < 0.05).
Coimmunoprecipitation
CoIP assays were performed as described by Langlois et al. (2008)
. In brief, 1 mg of protein from each lysate was incubated in IP buffer (see above) overnight at 4°C in the presence of 10 µg/ml anti-Panx1, -Panx2 (Zymed/Invitrogen) or -Panx3 affinity purified antibodies. Complexes were collected by incubating the mixtures for 2 h at 4°C with 30 µl (50% slurry) of protein A-Sepharose beads. Several washes with 500 µl of IP buffer removed unspecific binding proteins. Beads were dried by aspiration and resuspended in 2x Laemmli buffer (reducing conditions), boiled for 5 min, run in 8% SDS-PAGE gels and transferred to nitrocellulose membranes to be probed with the specific anti-pannexin antibodies.
Because all antibodies used were generated in rabbits, it was necessary to use the Clean-Blot IP Detection Reagent (horse radish peroxidase; Pierce Chemical) as a secondary antibody. This reagent binds preferentially to native immunoglobulin G (IgG) and not denatured IgG, minimizing the appearance of IgG bands in the blots. It was used in a 1:4000 dilution and after washes with 0.05% Tween 20 in PBS, the signal was detected with a SuperSignal West Femto chemiluminescent kit (Pierce Chemical). When more than one probing was necessary for the same blot, the membrane was not stripped (to avoid reduction in signal) and was subsequently probed with the second rabbit-derived antibody, followed by a goat anti-rabbit Alexa Fluor 680 secondary antibody for detection on an Odyssey infrared imaging system (LI-COR). In this case, IgG bands were visible after using the anti-rabbit fluorescent secondary antibody.
Immunoprecipitation controls for all three antibodies were performed by IP of singly transfected 293T cells expressing Panx1 or Panx2 and pulled down with the opposite antibody (Panx2 or Panx3 antibodies) to rule out any cross-talk between antibody specificities (Supplemental Figure 1).
Dye Uptake Experiments and Statistics
One hundred thousand 293T cells per dish were plated in 35-mm culture dishes coated with 0.5 mg/ml collagen I in 60% ethanol. The cells were transfected the next day with the various pannexin constructs or cotransfected with two constructs as described above. Control 293T cells were transfected with free GFP to monitor transfection efficiency and background dye uptake. After 48–72 h posttransfection, all cultures were kept on ice and subjected to sulforhodamine B (mol. wt. 558.7; Invitrogen) dye uptake assays under conditions of physiological Ca++ and Mg++ and mechanical stimulation as we described in detail previously (Penuela et al., 2007
). ImageJ (National Institutes of Health, Bethesda, MD) was used for quantification of the dye uptake incidence per field (three random 20x fields near the stimulation target were averaged per dish). Parallel control experiments were done using dextran rhodamine dye. Experiments included four independent transfections and were assessed by one-way analysis of variance (ANOVA) followed by a Tukey test.
RESULTS
Sequence Analysis and Cloning of Mouse Panx2
The three National Center for Biotechnology Information protein reference sequences (RefSeq) annotated for mouse Panx1, Panx2, and Panx3 were analyzed with a Toppred algorithm (Claros and Heijne, 1994
) to predict their topology and identify the location of their transmembrane domains. As shown in Figure 1, all three murine pannexins are predicted to have intracellular amino tails and carboxy tails, as well as four transmembrane domains, each of 20 amino acids. As we reported previously, Panx1 and Panx3 have a consensus site for N-linked glycosylation on amino acids N254 and N71, respectively (Penuela et al., 2007
). Using the NetN-Glyc1.0 server (Blom et al., 2004
), we found that Panx2 also encodes a potential N-linked glycosylation site at position N86 (Table 1) in its first extracellular loop domain, similar to Panx3. Based on the Toppred-predicted topology, Panx2 also exhibits a substantially larger carboxy tail compared with the other two pannexin family members.
|
2 kb, was cloned into expression vectors, validated by sequencing, and found to be identical to the annotated RefSeq with a predicted protein product of 677 amino acids (Table 1).
Site-directed Antibodies and Pannexin Characterization
Peptides for the generation of site-directed rabbit polyclonal antibodies (Table 1) were designed for each of the extracellular and intracellular domains of the pannexins (Figure 1). Out of those, six peptides and their corresponding antibodies were affinity purified and used in the characterization of pannexins in permeabilized 293T cells expressing Panx1, Panx2, or Panx3 (Figure 2). The Panx1 antibody, targeting the second extracellular loop (EL2-247), showed specific labeling at both cell surface and intracellular compartments (Figure 2A). In Western blots, EL2-247, revealed a similar banding profile to our previously reported anti-Panx1 CT-395 antibody (Penuela et al., 2007
), and the corresponding peptide competition indicated that it is specific (Figure 2B). The Panx2 antibody (CT-494) exhibited specificity for Panx2, whereas the control preimmune serum did not show any significant labeling (Figure 2A, inset). Western blots of Panx2-expressing cells by using the CT-494 antibody highlighted a band of
80 kDa, but because the antibody presented higher than desirable background signal (data not shown), in further immunoblotting experiments we chose to use the commercially available rabbit anti-Panx2 antibody C terminus (Zymed Laboratories/Invitrogen). The Zymed anti-Panx2 antibody also recognized a band of
80 kDa (Figure 2B) that occasionally presented as a doublet in Western blots of 293T cells expressing mouse Panx2. All Panx3 antibodies derived from three distinct protein epitopes, recognized a doublet band of
43 kDa as was reported earlier for CT-379 (Penuela et al., 2007
), and the labeling was effectively eliminated by preadsorption with the cognate peptides (Figure 2B). Both, Panx3 EL1-84 and IL-169 antibodies, when used for immunolabeling of Panx3-expressing 293T cells, were particularly effective in identifying both intracellular and cell surface Panx3. From this library of novel anti-pannexin antibodies, we used the CT-395 anti-Panx1 antibody, the CT-379 anti-Panx3 antibody, and the CT-494 anti-Panx2 antibody for all further immunolabeling studies reported here. The Zymed Laboratories/Invitrogen rabbit anti-mouse Panx2 antibody was used for all immunoblotting assays.
|
|
|
|
|
|
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
To aide in the characterization of this diverse family of proteins, we generated a new set of site-specific antibodies that could target not only the C termini of each protein as reported previously (Penuela et al., 2007
) but also antibodies specific for their extracellular domains and intracellular loops. Having antibodies to two or three pannexin epitopes that exhibited similar patterns of immunolabeling and immunoblotting further validated the specificity of these antibodies and the identity of all expressed pannexin species. This is particularly important for pannexins because they are encoded on four to five exons (Baranova et al., 2004
). This gene arrangement allows for the possibility of splice variants that can result in proteins of different sizes and, possibly, alternative functions. For example, the human PANX1 and PANX2 genes have recently been reported to be differentially spliced (Baranova et al., 2004
; Ma et al., 2008
), generating two splice variants of each protein, and PANX1a and b seem to have unique expression patterns (Ma et al., 2008
).
Even though all three pannexins have a single predicted glycosylation site in their first (Panx2 and Panx3) or second (Panx1) extracellular loops, their level of glycosylation is highly diverse. Although Panx1 and Panx3 present core, high-mannose and complex glycoprotein forms, Panx2 is only glycosylated to a high-mannose form that manifests as a minor shift in gel mobility. Interestingly, the ability of all these forms to traffic to the cell surface is also varied. Complex glycoprotein species of Panx1 and Panx3 readily traffic to the cell surface, but although less efficient, the core and intermediate forms of Panx1 and Panx3 also reach the cell surface and function as channels in dye uptake. Previous reports revealed that the Gly0 form of mouse Panx1 did in fact reach the cell surface in HeLa cells (Huang et al., 2007a
), and to a lesser extent, so did the glycosylation-deficient form of rat Panx1 (Boassa et al., 2007
). The capacity of unglycosylated Panx1 to reach the cell surface may be governed by the cell type, other coexpressed pannexins or even other unknown pannexin-binding partners. A recent report by Prochnow et al. (2009)
showed that in zebrafish, the glycosylation-deficient mutant zfPanx1-N246K can traffic to the cell surface, but its ability to take up ethidium bromide was impaired compared with wild-type zfPanx1. Thus, in vivo, unglycosylated species of Panx1 and Panx3 may have the potential to reach and function at the cell surface as single-membrane channels or possibly, without the steric interference of their large glycan chains, even dock with opposed pannexons to form intercellular channels. The concept of unglycosylated Panx1 forming an intercellular channel was postulated in a report that saw increased junctional conductance of frog oocytes expressing rat Panx1 upon removal of carbohydrate moieties with an N-glycosidase F treatment (Boassa et al., 2008
). Given that immunofluorescent studies revealed the bulk of Panx2 within intracellular compartments, it was somewhat surprising to detect a subpopulation of Panx2 at the plasma membrane, and furthermore, to find that cell surface Panx2 could function in dye uptake, albeit less well than Panx1 or Panx3. In one other study, rat Panx2 was reported to localize to the cell surface when expressed in HeLa cells (Zappala et al., 2006
). Collectively, these studies strongly suggest that a population of all three pannexin family members can reside and function at the cell surface as single-membrane channels. In the future, it will be interesting to determine whether both glycosylated and unglycosylated pannexin species are in fact present at the cell surface in vivo.
To begin to understand the functional characteristics of pannexin family members, it is critical to determine which pannexin family members interact. In the present study, we investigate all possible pannexin interactions through a series of colocalization, coimmunoprecipitation and rescue studies. The strongest and most robust interactions were found between the Gly0 and Gly1 species of Panx1 and Panx2. These data support an interaction between Panx1 and Panx2 that is initiated, while these pannexins are still residents of the endoplasmic reticulum. Although it is not possible to confirm a direct interaction between these two family members, these findings are consistent with the potential formation of mixed Panx1/2 channels that result in decreased channel function as suggested by our dye uptake assays. These new findings are in keeping with previous data in which the coinjection of rat Panx1 and Panx2 RNA in Xenopus laevis oocytes resulted in "hemichannels" or intercellular channels with attenuated functional properties from channels formed by Panx1 alone (Bruzzone et al., 2003
). Although these authors never demonstrated the interaction of untagged Panx1 and Panx2 in this study, they later showed that Myc tagged rat Panx1 did coimmunoprecipitate with GFP-tagged Panx2 (Bruzzone et al., 2005
). Together with our findings, it is tempting to postulate that the function of Panx2 is mainly to modulate Panx1 channels.
We had shown previously that many tissues and some cultured cell types coexpress Panx1 and Panx3 (Penuela et al., 2007
, 2008
), and because they share the highest homology levels among the family members, we hypothesized that they could also interact. Panx1 and Panx3 partially colocalize in NRK and 293T cells, and coimmunoprecipitation assays revealed that they physically interact. However, Panx1 and Panx3 interaction is limited and favors situations when Panx1 is not glycosylated or glycosylated to only the Gly1 species. These studies would predict that when Panx1 and Panx3 are fully glycosylated they are less likely to interact and more likely exist in homomeric arrangements as single-membrane channels at the cell surface. It is important to note that the results obtained with the Panx1 glycosylation mutant, could be attributable to misfolding of the protein, because glycosylation is important for quality control in the cell. However, the naturally occurring Gly0 form of Panx1 displayed similar properties, indicating that it is not merely an aberrant form of Panx1 but an entity that can traffic and function. Not surprisingly, because Panx2 and Panx3 are rarely if ever coexpressed in the same cell all of our evidence would suggest that they do not interact.
Further support of selective interpannexin interactions can be obtained using the trafficking and functional defective Panx3-GFP variant of Panx3. For example, we found that the Panx1 and Panx3 glycosylation-deficient mutants could uptake sulforhodamine B dye, yet when coexpressed with any combination of Panx3-GFP, no significant dye uptake was observed. Clearly, this finding provides supportive evidence that Panx1 and Panx3 can in fact interact, although intermixing of the untagged versions of Panx1 and Panx3 did not seem to alter channel function. Furthermore, the GFP tag not only affects normal Panx3 trafficking but also transforms the Panx3-GFP chimera into a dominant-negative mutant that cross-talks with Panx1 in addition to blocking the channel function of coexpressed Panx3.
In summary, the diverse subcellular distribution profiles observed for the glycoprotein family of channel forming pannexins in vitro and in vivo can be partially explained by their interactions with other members of the family. Furthermore, these interactions seem to be highly regulated by the glycosylation state of each pannexin and their intermixing can significantly affect the functional outcome. Further studies on the behavior of homomeric and heteromeric pannexin channels will be crucial to facilitate the complete understanding of the scope of pannexin functions in the cell.
| ACKNOWLEDGMENTS |
|---|
| Footnotes |
|---|
Address correspondence to: Dale W. Laird (dale.laird{at}schulich.uwo.ca).
| REFERENCES |
|---|
|
|
|---|
Baranova, A. et al. (2004). The mammalian pannexin family is homologous to the invertebrate innexin gap junction proteins. Genomics 83, 706–716.[CrossRef][Medline]
Blom, N., Sicheritz-Ponten, T., Gupta, R., Gammeltoft, S., and Brunak, S. (2004). Prediction of post-translational glycosylation and phosphorylation of proteins from the amino acid sequence. Proteomics 4, 1633–1649.[CrossRef][Medline]
Boassa, D., Ambrosi, C., Qiu, F., Dahl, G., Gaietta, G., and Sosinsky, G. (2007). Pannexin1 channels contain a glycosylation site that targets the hexamer to the plasma membrane. J. Biol. Chem 282, 31733–31743.
Boassa, D., Qiu, F., Dahl, G., and Sosinsky, G. (2008). Trafficking dynamics of glycosylated Pannexin1 proteins. Cell. Commun. Adhes 15, 119–132.[CrossRef][Medline]
Bruzzone, R., Barbe, M. T., Jakob, N. J., and Monver, H. (2005). Pharmacological properties of homomeric and heteromeric pannexin hemichannels expressed in Xenopus oocytes. J. Neurochem 92, 1033–1043.[CrossRef][Medline]
Bruzzone, R., and Dermietzel, R. (2006). Structure and function of gap junctions in the developing brain. Cell Tissue Res 26, 239–248.
Bruzzone, R., Hormuzdi, S. G., Barbe, M. T., Herb, A., and Monyer, H. (2003). Pannexins, a family of gap junction proteins expressed in brain. Proc. Natl. Acad. Sci. USA 100, 13644–13649.
Claros, M. G., and Heijne, G. V. (1994). TopPred II: an improved software for membrane protein structure predictions. CABIOS 10, 685–686.[Medline]
Dvoriantchikova, G., Ivanov, D., Panchin, Y., and Shestopalov, V. I. (2006a). Expression of pannexin family of proteins in the retina. FEBS Lett 580, 2178–2182.[CrossRef][Medline]
Dvoriantchikova, G., Ivanov, D., Pestova, A., and Shestopalov, V. (2006b). Molecular characterization of pannexins in the lens. Mol. Vis 12, 1417–1426.[Medline]
Harris, A. L. (2007). Connexin channel permeability to cytoplasmic molecules. Prog. Biophys. Mol. Biol 94, 120–143.[CrossRef][Medline]
Huang, Y., Grinspan, J. B., Abrams, C. K., and Scherer, S. S. (2007a). Pannexin1 is expressed by neurons and glia but does not form functional gap junctions. Glia 55, 46–56.[CrossRef][Medline]
Huang, Y.-J., Maruyama, Y., Dvoryanchikov, G., Pereira, E., Chaudhari, N., and Roper, S. D. (2007b). The role of pannexin 1 hemichannels in ATP release and cell-cell communication in mouse taste buds. Proc. Natl. Acad. Sci. USA 104, 6436–6441.
Koval, M. (2006). Pathways and control of connexin oligomerization. Trends Cell Biol 16, 159–166.[CrossRef][Medline]
Langlois, S., Cowan, K. N., Shao, Q., Cowan, B. J., and Laird, D. W. (2008). Caveolin-1 and -2 interact with connexin43 and regulate gap junctional intercellular communication in keratinocytes. Mol. Biol. Cell 19, 912–928.
Locovei, S., Bao, L., and Dahl, G. (2006). Pannexin 1 in erythrocytes: function without a gap. Proc. Natl. Acad. Sci. USA 103, 7655–7659.
Ma, W., Hui, H., Pelegrin, P., and Surprenant, A. (2008). Pharmacological characterization of pannexin-1 currents expressed in mammalian cells. J. Pharmacol. Exp. Ther 328, 409–418.[CrossRef][Medline]
Panchin, Y., Kelmanson, I., Matz, M., Lukyanov, K., Usman, N., and Lukyanov, S. (2000). A ubiquitous family of putative gap junction molecules. Curr. Biol 10, R473–R474.[CrossRef][Medline]
Pelegrin, P., and Surprenant, A. (2006). Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor. EMBO J 25, 5071–5082.[CrossRef][Medline]
Pelegrin, P., and Surprenant, A. (2007). Pannexin-1 couples to maitotoxin- and nigericin-induced interleukin-1beta release through a dye uptake-independent pathway. J. Biol. Chem 282, 2386–2394.
Penuela, S., Bhalla, R., Gong, X.-Q., Cowan, K. N., Celetti, S. J., Cowan, B. J., Bai, D., Shao, Q., and Laird, D. W. (2007). Pannexin 1 and pannexin 3 are glycoproteins that exhibit many distinct characteristics from the connexin family of gap junction proteins. J. Cell Sci 120, 3772–3783.
Penuela, S., Celetti, S. J., Bhalla, R., Shao, Q., and Laird, D. W. (2008). Diverse subcellular distribution profiles of pannexin1 and pannexin3. Cell. Commun. Adhes 15, 133–142.[CrossRef][Medline]
Prochnow, N., Hoffmann, S., Vroman, R., Klooster, J., Bunse, S., Kamermans, M., Dermietzel, R., and Zoidl, G. (2009). Pannexin1 in the outer retina of the zebrafish, Danio rerio. Neuroscience 162, 1039–1054.[CrossRef][Medline]
Ransford, G. A., Fregien, N., Qiu, F., Dahl, G., Conner, G. E., and Salathe, M. (2009). Pannexin 1 contributes to ATP release in airway epithelia. Am. J. Respir. Cell Mol. Biol DOI: 2010.1165/rcmb.2008-0367OC.[CrossRef]
Ray, A., Zoidl, G., Wahle, P., and Dermietzel, R. (2006). Pannexin expression in the cerebellum. Cerebellum 5, 189–192.[CrossRef][Medline]
Ray, A., Zoidl, G., Weickert, S., Wahle, P., and Dermietzel, R. (2005). Site-specific and developmental expression of pannexin1 in the mouse nervous system. Eur. J. Neurosci 21, 3277–3290.[CrossRef][Medline]
Silverman, W. R., De Rivero Vaccari, J. P., Locovei, S., Qiu, F., Carlsson, S. K., Scemes, E., Keane, R. W., and Dahl, G. (2009). The pannexin 1 channel activates the inflammasome in neurons and astrocytes. J. Biol. Chem 284, 18143–18151.
Solan, J. L., and Lampe, P. D. (2005). Connexin phosphorylation as a regulatory event linked to gap junction channel assembly. Biochim. Biophys. Acta 1711, 154–163.[Medline]
Tang, W., Ahmad, S., Shestopalov, V. I., and Lin, X. (2008). Pannexins are new molecular candidates for assembling gap junctions in the cochlea. Neuroreport 19, 1253–1257.[CrossRef][Medline]
Tarentino, A. L., and Plummer, T.H.J. (1987). Peptide-N4-(N-acetyl-beta-glucosaminyl) asparagine amidase and endo-beta-N-acetylglucosaminidase from Flavobacterium meningosepticum. Methods Enzymol 138, 770–778.[Medline]
Tatusova, T. A., and Madden, T. L. (1999). Blast 2 sequences—a new tool for comparing protein and nucleotide sequences. FEMS Microbiol. Lett 174, 247–250.[CrossRef][Medline]
Thompson, R. J., Jackson, M. F., Olah, M. E., Rungta, R. L., Hines, D. J., Beazely, M. A., MacDonald, J. F., and MacVicar, B. A. (2008). Activation of pannexin-1 hemichannels augments aberrant bursting in the hippocampus. Science 322, 1555–1559.
Thompson, R. J., Zhou, N., and MacVicar, B. A. (2006). Ischemia opens neuronal gap junction hemichannels. Science 312, 924–927.
Vogt, A., Hormuzdi, S. G., and Monyer, H. (2005). Pannexin1 and pannexin2 expression in the developing and mature rat brain. Mol. Brain Res 141, 113–120.[Medline]
Willecke, K., Eiberger, J., Degen, J., Eckardt, D., Romualdi, A., Guldenagel, M., Deutsch, U., and Sohl, G. (2002). Structural and functional diversity of connexin genes in the mouse and human genome. Biol. Chem 383, 725–737.[CrossRef][Medline]
Zappala, A., Cicero, D., Serapide, M. F., Paz, C., Catania, M. V., Falchi, M., Parenti, R., Panto, M. R., La Delia, F., and Cicirata, F. (2006). Expression of pannexin1 in the CNS of adult mouse: cellular localization and effect of 4-aminopyridine-induced seizures. Neuroscience 141, 167–178.[CrossRef][Medline]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||